• In-person Keynote & Exhibit Hall Pass: In-person Keynote Presentation & Exhibit Hall Pass (Receives access to March 6, 3:45 J. Craig Venter keynote presentation. Also receives access to event exhibit hall and March 6 reception)

• Free Hall Pass includes access to the presentations here.

Exhibit Hall Schedule**

Please note that this is a conference-driven event. The exhibit hall is open during the hours listed below. The dedicated viewing times reflect those times when there is a break in the conference session rooms. (All times (PST) Pacific Standard Time)

**Exhibit hours are subject to change.**

30th ANNIVERSARY OF TRI-CON PLENARY KEYNOTE SESSION: GENOMICS INNOVATION

3:40 pm Chairperson's Remarks
Kevin Davies, PhD, Executive Editor, The CRISPR Journal; Author, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing

3:45 pm FIRESIDE CHAT: Sequences, SynBio, and Sailing: Three Decades of Adventure with J. Craig Venter
Kevin Davies, PhD, Executive Editor, The CRISPR Journal; Author, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing

J. Craig Venter, PhD, Founder, Chairman, and CEO, J. Craig Venter Institute
Since his riveting publication on expressed sequence tags in 1991, which galvanized a revolution in genomics, J. Craig Venter has been a dominant figure in the world of genomics and biotechnology. As the first human to have his personal genome completely sequenced, and as the co-founder of Synthetic Genomics and Human Longevity, he is routinely one step ahead of his peers. As we celebrate 30 years of TRI-CON, we’re thrilled to host Dr. Venter who will discuss his life, his many accomplishments, and his vision for the future of precision medicine and the biotech industry.

4:15 pm PANEL DISCUSSION: 30 Years of Genomics Innovation and the Future of Precision Medicine
Moderator: Kevin Davies, PhD, Executive Editor, The CRISPR Journal; Author, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing
Over the past three decades, genomic medicine has been transformed from a distant dream to a clinical reality. With patients suffering genetic diseases and cancer now cured thanks to advances in genomics, cell therapy, genome editing, and computing, the future is bright – but by no means assured. In this TRI-CON keynote panel, we discuss the scientific highlights of an extraordinary journey for practitioners of precision medicine and anticipate where the field is headed.

Panelists:

Euan Ashley, PhD, Professor, Genomics & Precision Health, Stanford School of Medicine

J. Craig Venter, PhD, Founder, Chairman, and CEO, J. Craig Venter Institute

Molly He, PhD, CEO & Co Founder, Element Biosciences

Alex Aravanis, MD, PhD, CTO, Senior Vice President, Head of Research and Product Development, Illumina

5:00 Welcome Reception in the Exhibit Hall with Poster Viewing

• Premium: In-person Keynote Presentation & Exhibit Hall Pass (Receives access to all 5 keynote presentations from March 6-8, 2023 and access to event exhibit hall and March 6 reception).

• Premium Hall Pass includes access to all the presentations here.

Exhibit Hall Schedule**

Please note that this is a conference-driven event. The exhibit hall is open during the hours listed below. The dedicated viewing times reflect those times when there is a break in the conference session rooms. (All times (PST) Pacific Standard Time)

**Exhibit hours are subject to change.**